نتائج البحث

Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China's responses to address secondary cancer risks of CAR-T therapy.

• Authors : Tan, Ruirong¹ (AUTHOR); Li, Rui² (AUTHOR); Dai, Meng-Yuan³ (AUTHOR)

• Source: Journal of Hematology & Oncology. 10/8/2024, Vol. 17 Issue 1, p1-4. 4p.

تفاصيل العنوان

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

• Authors : Cesaro, S; Mikulska, M; Hirsch, HH

Subjects: Medicin och hälsovetenskap

• Source: Leukemia. 37(9):1933-1938

تفاصيل العنوان

Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China’s responses to address secondary cancer risks of CAR-T therapy

• Authors : Ruirong Tan; Rui Li; Meng-Yuan Dai

Subjects: CAR-T therapy; Secondary cancers; Drug regulation

• Source: Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-4 (2024)

تفاصيل العنوان

Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trial.

• Authors : Volkov, Jenell; Nunez, Daniel; Mozaffar, Tahseen

Subjects: Humans; Antigens; CD19

• Source: Molecular Therapy. 32(11)

تفاصيل العنوان

BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma

• Source: BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma：A Prospective, Single-center,

تفاصيل العنوان

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

• Source: Understanding the Mechanisms of Clonal and Non-Clonal Cytopenia Following CAR-T Therapy

تفاصيل العنوان

Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials.

• Authors : Chitkara, Akshit; Sreenivasan, Sushanth; Yin, Yue

Subjects: B-cell lymphoma; Chimeric Antigen Receptor T-cell (CAR-T); hematological malignancies

• Source: Current Oncology. 31(8)

تفاصيل العنوان

PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy

• Authors : The V Foundation; C. Babis Andreadis, Principal Investigator

• Source: A Phase I/Ib PET Imaging Study of 64Cu-GRIP B, a Radiotracer Targeting Granzyme B, in Patients Receiving CD19-directed CAR-T

تفاصيل العنوان

Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy

• Source: A Study of Longitudinal Neurocognitive and Neuroimaging Evaluations for Adult Patients With Lymphoma Receiving CD19 CAR T Cell

تفاصيل العنوان

KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome

• Source: KYSA-8: A Phase 2 Open-Label, Single-Arm, Multicenter Study of KYV 101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T Cell (CD19

تفاصيل العنوان